全文获取类型
收费全文 | 97948篇 |
免费 | 6943篇 |
国内免费 | 379篇 |
专业分类
耳鼻咽喉 | 1102篇 |
儿科学 | 2302篇 |
妇产科学 | 1337篇 |
基础医学 | 13234篇 |
口腔科学 | 1279篇 |
临床医学 | 10094篇 |
内科学 | 20754篇 |
皮肤病学 | 1385篇 |
神经病学 | 9817篇 |
特种医学 | 4255篇 |
外科学 | 16302篇 |
综合类 | 996篇 |
一般理论 | 96篇 |
预防医学 | 6575篇 |
眼科学 | 2171篇 |
药学 | 6525篇 |
中国医学 | 107篇 |
肿瘤学 | 6939篇 |
出版年
2024年 | 66篇 |
2023年 | 835篇 |
2022年 | 1304篇 |
2021年 | 2906篇 |
2020年 | 1696篇 |
2019年 | 2648篇 |
2018年 | 3030篇 |
2017年 | 2220篇 |
2016年 | 2396篇 |
2015年 | 2844篇 |
2014年 | 3969篇 |
2013年 | 4920篇 |
2012年 | 7959篇 |
2011年 | 8309篇 |
2010年 | 4649篇 |
2009年 | 4115篇 |
2008年 | 6691篇 |
2007年 | 6924篇 |
2006年 | 6423篇 |
2005年 | 6303篇 |
2004年 | 5691篇 |
2003年 | 5204篇 |
2002年 | 4752篇 |
2001年 | 778篇 |
2000年 | 536篇 |
1999年 | 741篇 |
1998年 | 938篇 |
1997年 | 747篇 |
1996年 | 562篇 |
1995年 | 506篇 |
1994年 | 467篇 |
1993年 | 441篇 |
1992年 | 305篇 |
1991年 | 240篇 |
1990年 | 216篇 |
1989年 | 198篇 |
1988年 | 185篇 |
1987年 | 149篇 |
1986年 | 158篇 |
1985年 | 158篇 |
1984年 | 196篇 |
1983年 | 161篇 |
1982年 | 246篇 |
1981年 | 237篇 |
1980年 | 173篇 |
1979年 | 100篇 |
1978年 | 122篇 |
1977年 | 102篇 |
1976年 | 71篇 |
1975年 | 65篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
A. Robert Spitzer Shalom Stahl David Yarnitsky Ernest W. Johnson John R. Wilson R. A. C. Hughes Stefania Morino Giovanni Antonini Kiyotoshi Kaneko Yoji Ohnishi Tetsushi Atsumi Isao Hozumi Tadashi Miyatake Tetsuo Furukawa James P. Knochel Ikuo Mineo Seiichiro Tarui Francis O. Walker Andrew J. Gitter Walter C. Stolov Nicholas J. Capozzoli 《Muscle & nerve》1996,19(4):531-538
62.
K. Hamano Hiroshi Ito Andrew Bushell Kathryn J. Wood Kensuke Esato 《Transplant international》1997,10(4):293-298
In this study, the effect of combining anti-CD4 monoclonal antibody (mAb) and cyclosporin (CyA) therapy at the time of transplantation
was examined. A mouse cardiac allograft model was used. Anti-CD4 mAb administered perioperatively induces long-term survival.
The addition of a short course of CyA given subcutaneously in a regimen of either a high-dose treatment or a standard dose
treatment to the anti-CD4 mAb treatment protocol did not have a detrimental effect on graft survival. Despite having no significant
effect on graft survival, the addition of CyA to the treatment protocol did result in a significant decrease in the level
of IL-2 present in the hearts 7 days after transplantation. The decrease in IL-2 production was directly related to the presence
of CyA in vivo. When CyA treatment was continued throughout the period during which unresponsiveness to the graft is induced
by anti-CD4 mAb therapy, 50 % of the grafted hearts were rejected once the CyA was discontinued. In conclusion, the combined
use of anti-CD4 mAb therapy and CyA did not have a negative effect on graft survival in this model when the two agents were
used concurrently at the time of transplantation.
Received: 2 October 1996 Received after revision: 31 January 1997 Accepted: 5 February 1997 相似文献
63.
64.
Dr. Andrew G. Bostom M.D. Dr. Anne L. Hume Pharm.D. Dr. Charles B. Eaton M.D. Dr. Joseph P. Laurino Ph.D. Ms. Lisa R. Yanek B.A. Ms. Mary S. Regan B.S. Mr. William H. McQuade M.P.H. Dr. Wendy Y. Craig Ph.D. Ms. Gayle Perrone M.B.A. Dr. Paul F. Jacques Sc.D. 《Pharmacotherapy》1995,15(4):458-464
Study Objective . To determine the efficacy of high-dose ascorbate supplementation in lowering lipoprotein(a) [Lp(a)] levels in patients with premature coronary heart disease (CHD). Design . Randomized, double-blind, placebo-controlled trial. Setting . Outpatient clinic. Patients . Forty-four patients with documented premature CHD. defined as confirmed myocardial infarction and/or angiographically determined stenosis of 50% or greater in at least one major coronary artery before age 60 years. Interventions . Patients were block randomized on the basis of age, gender, and screening Lp(a) concentrations to receive ascorbate 4.5 g/day or placebo for 12 weeks. Measurements and Main Results . High-dose ascorbate was well tolerated and produced a marked elevation in mean plasma ascorbate levels (+1.2 mg/dl; p<0.001). Multiple linear regression analysis revealed no significant effect of supplementation on postintervention Lp(a) levels (p=0.39) in a model that included treatment group assignment, and baseline Lp(a) levels. Conclusions . Our findings do not support a clinically important lowering effect of high-dose ascorbate on plasma Lp(a) in patients with premature CHD. 相似文献
65.
Andrew R. Hoellein MD Christopher A. Feddock MD Charles H. Griffith III MD MSPH John F. Wilson PhD Donald R. Barnett MD MSPH Pat F. Bass III MD MS T. Shawn Caudill MD MSPH 《Journal of general internal medicine》2004,19(5P2):562-565
Due to recent public debate and newly imposed resident work hour restrictions, we decided to investigate the relationship of resident call status to their ambulatory patients' satisfaction. Resident continuity clinic patients were asked to rate their level of satisfaction on a 10-point Likert-type scale. Using multiple regression approaches, these data were then assessed as a function of resident call status. We found that in 646 patient encounters, patient satisfaction scores were significantly less when the resident was postcall, 8.99 ± 1.8, than when not postcall, 9.31 ± 1.3. We herein discuss etiologies and implications of these findings for both patient care and medical education. 相似文献
66.
Use of suture-mediated vascular closure devices for the management of femoral vein access after transcatheter procedures. 总被引:1,自引:0,他引:1
James A Shaw Elizabeth Dewire Alan Nugent Andrew C Eisenhauer 《Catheterization and cardiovascular interventions》2004,63(4):439-443
Groin complications remain the most common complication of cardiac catheterization procedures. While the use of closure devices is increasing for arterial sheaths, venous sheaths tend to be removed and hemostasis achieved with manual compression. We report our experience using Perclose suture-mediated vascular closure device to achieve hemostasis and early mobility in patients who have had venous access as part of their procedure. There were a total of 42 patients (21 males; average age, 63.5 years) studied. The majority of the patients had 7 Fr sheaths (24), with access sites of sheaths up to 14 Fr being closed with this technique. Two patients developed complications at the access site: one patient requiring rehospitalization for intravenous antibiotics because of late access site infection, and one patient with deep venous thrombosis and pulmonary emboli. We conclude that the use of the Perclose suture-mediated closure device for closure of femoral venous access sites is feasible and should be considered especially in patients with larger venous sheaths and those at increased risk of groin complications. 相似文献
67.
68.
69.
70.